Literature DB >> 10653008

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor.

A Pettersson1, J A Nagy, L F Brown, C Sundberg, E Morgan, S Jungles, R Carter, J E Krieger, E J Manseau, V S Harvey, I A Eckelhoefer, D Feng, A M Dvorak, R C Mulligan, H F Dvorak.   

Abstract

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is an angiogenic cytokine with potential for the treatment of tissue ischemia. To investigate the properties of the new blood vessels induced by VPF/VEGF, we injected an adenoviral vector engineered to express murine VPF/VEGF164 into several normal tissues of adult nude mice or rats. A dose-dependent angiogenic response was induced in all tissues studied but was more intense and persisted longer (months) in skin and fat than in heart or skeletal muscle (< or =3 weeks). The initial response (within 18 hours) was identical in all tissues studied and was characterized by microvascular hyperpermeability, edema, deposition of an extravascular fibrin gel, and the formation of enlarged, thin-walled pericyte-poor vessels ("mother" vessels). Mother vessels developed from preexisting microvessels after pericyte detachment and basement membrane degradation. Mother vessels were transient structures that evolved variably in different tissues into smaller daughter vessels, disorganized vessel tangles (glomeruloid bodies), and medium-sized muscular arteries and veins. Vascular structures closely resembling mother vessels and each mother vessel derivative have been observed in benign and malignant tumors, in other examples of pathological and physiological angiogenesis, and in vascular malformations. Together these data suggest that VPF/VEGF has a role in the pathogenesis of these entities. They also indicate that the angiogenic response induced by VPF/VEGF is heterogeneous and tissue specific. Finally, the muscular vessels that developed from mother vessels in skin and perimuscle fat have the structure of collaterals and could be useful clinically in the relief of tissue ischemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653008     DOI: 10.1038/labinvest.3780013

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  116 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement.

Authors:  B S Jacobson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

Authors:  C Sundberg; J A Nagy; L F Brown; D Feng; I A Eckelhoefer; E J Manseau; A M Dvorak; H F Dvorak
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Vascularization of the dermal support enhances wound re-epithelialization by in situ delivery of epidermal keratinocytes.

Authors:  Liana M Lugo; Pedro Lei; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2010-12-18       Impact factor: 3.845

5.  Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription.

Authors:  Guangqi E; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

6.  Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma.

Authors:  Harold F Dvorak
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

7.  VEGF protein in human ischemic skeletal muscle.

Authors:  Martin Flück; Thomas Gustafsson
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Glomeruloid microvascular proliferation in angiomyomatous hamartoma of the lymph node.

Authors:  Jean-Louis Dargent; Laurence Lespagnard; Jean-Marc Verdebout; Pierre Bourgeois; Denis Munck
Journal:  Virchows Arch       Date:  2004-06-19       Impact factor: 4.064

9.  A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.

Authors:  Daniel Voskas; Nina Jones; Paul Van Slyke; Celina Sturk; Wing Chang; Alex Haninec; Yael Olya Babichev; Jennifer Tran; Zubin Master; Stephen Chen; Nicole Ward; Maribelle Cruz; Jamie Jones; Robert S Kerbel; Serge Jothy; Lina Dagnino; Jack Arbiser; Giannoula Klement; Daniel J Dumont
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

10.  Chronic systemic hypoxia causes intra-retinal angiogenesis.

Authors:  Alex J Shortt; Katherine Howell; Colm O'Brien; Paul McLoughlin
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.